After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Want to turn your skills into cash? Explore ways to monetize your skills fast and increase your income.
19,128 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Two Nasdaq-100 trackers offer the same index path, but a small fee delta has produced a 6.86% trailing return gap ove...
With semiconductors powering AI and autos, investors are rethinking SMH inside Roth IRAs. This article examines the c...
The ITA ETF just ripped higher again, underscoring a multi-year upcycle in America’s rearmament push. Here’s what inv...
A dedicated pure-miner uranium fund has jumped 61% this year, outpacing broader uranium plays. Analysts say the move ...
This week, mortgage rates tick slightly higher but remain near the 6.5% level, according to Freddie Mac. The latest d...
In a market with muted yields, the idea that today’s small dividend could become a retirement engine is gaining tract...
When Wells Fargo reports earnings, the spotlight isn’t just on per-share figures. The real story this quarter is net ...
A couple faces a surprise $4,000 wedding debt after in-laws attach a repayment clause, prompting a warning about how ...
June’s producer price index fell 0.3% from May as energy prices slid, signaling cooling inflation. Yet geopolitical t...
Rowe Price unveils an actively managed multi-crypto ETF on NYSE Arca, signaling traditional fund managers’ growing ap...
Microsoft stock has fallen about 27% from its all-time high, but long‑term catalysts could help it double by 2030. Th...